Dalibor Hodko

Advisor at Grapheton

Dr. Dalibor Hodko has over 30 years of experience in developing and commercializing new cutting-edge technology in the areas of medical diagnostics, energy, clean technology, and healthcare. He received his M.Sc. and Ph.D. in chemical engineering and physical chemistry from the University of Zagreb, Croatia, and completed his postdoctoral work at Texas A&M University. His early R&D was performed at Rudjer Boscovic Institute, a National Lab of Croatia in areas of fundamental electrochemistry, surface science, and photochemistry. He was a founder of 3 startups and led the development of innovative technologies to commercialization. Dr. Hodko led and contributed to a growth of a startup from three to over 130 employees yielding a broad range of technologies and products developed. He served as a Director of Advanced Technology in a midsize biotech diagnostic company (Nanogen, Inc.) operating under FDA, GMP regulations and led innovative product development. Three of the technologies developed under the leadership of Dr. Hodko were commercialized including a portable point-of-care DNA analyzer, a clean-environmental technology for the treatment of contaminants in contaminated soils, and additive nanotechnology for plating electronic circuits using conducting polymers. Dr. Hodko developed pathways and networks that secured funding to startup companies through non-dilutive sources and partnerships totaling over $45 M. Dr. Hodko received three NASA awards for innovative technology development, has published 26 patents and has over 50 peer-reviewed publications.

Timeline

  • Advisor

    Current role